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‘Reverse innovation,’ a principle well established in the business world, describes the flow of ideas from emerging
to more developed economies. There is strong and growing interest in applying this concept to health care, yet
there is currently no framework for describing the stages of reverse innovation or identifying opportunities to
accelerate the development process. This paper combines the business concept of reverse innovation with
diffusion of innovation theory to propose a model for reverse innovation as a way to innovate in health care. Our
model includes the following steps: (1) identifying a problem common to lower- and higher-income countries;
(2) innovation and spread in the low-income country (LIC); (3) crossover to the higher-income country (HIC); and
(4) innovation and spread in the HIC. The crucial populations in this pathway, drawing from diffusion of innovation
theory, are LIC innovators, LIC early adopters, and HIC innovators. We illustrate the model with three examples of
current reverse innovations. We then propose four sets of specific actions that forward-looking policymakers,
entrepreneurs, health system leaders, and researchers may take to accelerate the movement of promising solutions
through the reverse innovation pipeline: (1) identify high-priority problems shared by HICs and LICs; (2) create slack
for change, especially for LIC innovators, LIC early adopters, and HIC innovators; (3) create spannable social
distances between LIC early adopters and HIC innovators; and (4) measure reverse innovation activity globally.Introduction
‘Reverse innovation’ — the flow of ideas from lower to
higher income settings — is gaining traction in health care
as a way to generate innovative ideas. A recent review ar-
ticle [1] identified examples spanning the six World Health
Organization (WHO) health system building blocks [2]
where developed countries benefited from ideas originat-
ing in developing countries. The Globalization and Health
theme issue on reverse innovation, which this paper intro-
duces, further expands this emerging literature.
Our paper presents a model for reverse innovation
(RI) in health care (Figure 1), drawing together core con-
cepts from the business and innovation literature. The
model describes an innovation pathway that begins with
the identification of a problem common to low-income
countries (LICs) and higher-income countries (HICs), an
innovation’s development and spread within the LIC, its
crossover to the HIC, and its spread in the HIC, thus
completing the RI process.
The model is useful in three ways. First, it provides a
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distribution, and reproduction in any mediumRI initiatives. Second, it reveals opportunities to intervene
and accelerate the movement of ideas through the RI
pathway. And third, it suggests metrics to track the pro-
gress of individual ideas along the RI pathway and to as-
sess, in the aggregate, the overall maturity of the field.
We begin by summarizing core concepts from the
business and innovation literature. We then describe the
model for RI in health care and illustrate it using three
current examples. Finally, we discuss specific actions
that policymakers, entrepreneurs, health system leaders,
and researchers can take to facilitate the movement of
promising ideas through the RI pipeline. We hope that by
encouraging this mechanism for diffusion of innovation,
key stakeholders will be incentivized to invest in these
technologies, which ultimately will benefit members of
LIC and HIC alike.Core concepts from the business and innovation literature
What is reverse innovation?
Reverse innovation refers to the process of first identifying
and/or fostering a successful innovation in a LIC that
addresses an unmet need in a HIC, then adapting and
spreading the innovation from the LIC to the HIC. It is, in
a nutshell, learning from and investing in poorer settingsntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Figure 1 Dynamics of innovation spread [3,4].
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require out-of-the-box solutions.
First described by Govindarajan and Trimble [3], RI can
be successful because of the unique characteristics of de-
veloping countries that provide powerful incentives, or
“gaps” that drive innovation. Five gaps have been described
in the literature. First, the market in LICs is typically higher
volume for lower price, or “value for many” instead of
“value for money [5].” Radically different approaches are
often needed to achieve satisfactory performance at ultra-
low price points, providing powerful incentives to create
low-cost devices of acceptable quality. Second, the physical
infrastructure is often underdeveloped, providing a “clean
slate” for rapid implementation of cutting edge products
and technologies. New systems and technology can be rap-
idly implemented without having to overcome the resis-
tance of convincing people to switch from existing, more
familiar systems and technologies. Third, there is pressure
for sustainability in resource-limited areas, favoring “green”
solutions due to larger and more rapidly growing popu-
lations whose consumption could deplete existing natural
resources and damage the local and global environment.
Fourth, fewer regulations in many LICs allow for faster pace
of innovations, which once proven in other parts of the
world may be more likely to pass through regulatory bodies
in HICs. Fifth, there are different preferences that inspire
creativity in design.
In the context of health care, a sixth factor is operative
in LICs: often overwhelming need, which adds urgency
and a moral imperative to create effective, scalable solu-
tions. In essence, stakeholders in LICs have more to gain
from the success of a targeted innovation, providing power-
ful incentive to generate creative solutions.
What is needed for diffusion of innovation in health care?
In applying the RI concept to health care, we draw upon
three influential ideas from diffusion of innovation theory.
First, what determines the dynamics of innovation
spread? Everett Rogers in his seminal work Diffusion ofInnovation [6] divides our society into five categories based
on their likelihood of adopting innovations (Figure 2):
(1) Innovators are the first individuals to adopt an
innovation. Comprising about 2.5% of the
population, innovators tend to have high social class,
high risk-tolerance, financial liquidity, and close
contact to other innovators. Innovation failures are
most common in this group, but financial resources
help absorb these losses.
(2) Early Adopters are the second group of individuals
to adopt an innovation. Making up about 13.5% of
the population, early adopters share several
characteristics with innovators (high social class,
financial liquidity), but they are more discrete in
their adoption choices and tend to have a high
degree of opinion leadership among their peers.
(3) Early Majority is the third adoption group.
Approximately 34% of the population, these
individuals tend to follow the lead of early adopters.
(4) Late Majority and (5) Laggards — the last groups
to adopt innovations.
Gladwell observed that when an innovation has been
adopted by 15-20% of the population, it may pass a “tip-
ping point,” beyond which spread is likely to occur
throughout the remainder of the system [7]. This thresh-
old falls somewhere between the tail end of the early
adopter group and the first part of the early majority.
Second, what influences the decision to adopt or reject
an innovation? According to Rogers, ideas that are easily
adoptable satisfy the following criteria; they are better
than existing alternatives, they are relevant to the local
context, they are simple and therefore easy to communi-
cate and understand, they are easily tested, and they are
visible to others.
Third, what can be done to accelerate innovation spread?
Drawing from across the innovation literature, Berwick of-
fered seven ‘rules’ to nurture innovation in his 2003 JAMA
Figure 2 A model for reverse innovation in health care.
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these, he later underlined these two:
(1) Create slack for change — innovation takes time,
money, energy, and resources as well as an openness
in the industry to make changes.
(2) Make early adopter activity visible — spread
requires social interaction, or the communication of
new ideas across a “spannable social distance” from
a credible source.
Core concepts from the business and innovation
literature








Dynamics of innovation spread (Rogers [6] and
Gladwell [8])
1. Innovators (2.5% of population) solve the problem.
2. Early adopters (13.5% of the population) identify and
endorse the solution, driving its spread.
3. A tipping point occurs with adoption by 15-20% of
the population, around the transition point from the
early adopters to the early majority.What drives adoption of an innovation? (Rogers [6])
5 factors:
1. Better
2. Relevant to local context
3. Simple
4. Easily tested
5. Visible to others
How do we accelerate innovation spread? (Berwick [4])
1. Create slack for change
2. Make early adopter activity visible
A model for reverse innovation in health care
We integrated the above concepts to create a new model
for reverse innovation in health care (Figure 1). This
model specifically explores the ‘crossover’ point where
ideas begin to transition between two distinct innovation
curves: the first originating in a LIC, and the second oc-
curring later in a HIC. The model has four steps: (1)
problem identification; (2) LIC innovation and spread;
(3) crossover; and (4) HIC innovation and spread.
Step 1: problem identification
The pathway for RI in health care begins with the identi-
fication of a high-priority problem that is: (1) common
to both LICs and HICs, and (2) subject to more favor-
able innovation conditions in the lower-income setting.
Examples of such problems range from the need for
low-cost and user-friendly diagnostics, to mobile health
information technology solutions, to the need to advance
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to-client delivery of health services. The five “innovation
gaps” of price, infrastructure, sustainability, regulations, and
preferences drive innovation by creating a favorable envir-
onment for new ideas to flourish. Whereas “innovation”
alone begins with local problem identification, RI begins
with identifying common problems, thus opening the possi-
bility for new forms of collaboration between stakeholders
in LICs and HICs.
Step 2: low-income country innovation and spread
Once a problem is identified, a sound solution must be
piloted by innovators and taken up by early adopters in
a LIC. Given the urgency of need and large gap between
needed and available care, sound healthcare innovations
will quickly spread in these settings. Creating slack for
change (in the form of time, money, personnel, etc.) for
LIC innovators to develop and test new ideas, and then
share these solutions with LIC early adopters can acceler-
ate this vital step. The vetting process by early adopters
can help improve the soundness of the solutions, as mea-
sured against Rogers’ five factors: that the innovation is
better, relevant, simple, easily tested, and visible to others.
Step 3: crossover
In order for RI to occur, the idea must cross-pollinate from
lower- to higher-income settings. Whereas innovation
spread within settings moves from early adopter to early
majority populations (as described above by Rogers in dif-
fusion of innovation theory), we argue that spread across
settings is more likely to move from LIC early adopters to
HIC innovators. This is a variation of Berwick’s make early
adopter activity visible rule: here, it is the HIC innovators
who need to form spannable social distances with LIC early
adopters. To accelerate the crossover step, new venues for
social interaction — in-person, virtual, synchronous, etc. —
could be developed, with additional slack provided to both
LIC early adopters and HIC innovators to foster transfer
and uptake of new ideas.
Step 4: high-income country innovation and spread
Once an idea has crossed over, it must then take hold in
the HIC. Rogers’ factors and Berwick’s rules apply, but
the specifics of what constitutes better, relevant, simple,
easily tested, visible to others, or the slack necessary for
change will all require recalibration for the new context.
For example, proof of superiority to existing technology
or standard of care in a clinical trial may be necessary
for uptake by HIC early adopters, and more rigorous
comparative and cost-effectiveness data may be needed
to convince the HIC early majority to change practice.
Resources must be allocated not only to support the
innovation and its spread, but also to repurpose existing
personnel or capacity that may be made obsolete by thenew method. LIC innovation spread may also be relevant:
if the idea has ‘tipped’ into the LIC early majority, then
HIC early adopters may be more likely to take it up.
Three examples of reverse innovation
We use three current RI examples to illustrate our model
(Table 1), one each from the WHO health system building
blocks of medical products, health information, and ser-
vice delivery. These three are real-world examples that
demonstrate the Reverse Innovation pathway in action:
1. Medical products — General Electric’s low-cost
MACi EKG machine [7] was developed after
identifying a need for a durable, portable, low cost
alternative to the current EKG technology in rural
India. Researchers in Bangalore created this tool
specifically for the LIC conditions, and after early
adopter success the EKG was modified and adapted
for US value-oriented customers [9] (Figure 3).
2. Health information — Ushahidi, a crowdsourcing
program used to map disaster impact and response
was first used during the 2008 Kenyan presidential
election and subsequently applied in the aftermath
of the 2010 Haiti earthquake. The widespread use of
mobile phones and lack of pre-existing
infrastructure in Kenya and Haiti created “gaps” or
ideal conditions for this technology. After success in
these LIC settings, Ushahidi “crossed over” for use
in the US state of Louisiana to monitor
infrastructure damage during hurricanes [10].
3. Service delivery — Partners In Health is a close-to
-client delivery model which was pioneered in rural
Haiti that uses community health workers and
wraparound services to address underlying social
determinants of health [11]. Geographic barriers to
conventional models and lack of existing medical
infrastructure in Haiti provided the demand for
innovation. The concept was successful in this low
resource setting and was subsequently adapted to
the US in the slightly modified PACT program.
Though existing formal research is limited, readers in-
terested in a review of current RI examples across the
six WHO health systems building blocks may wish to
read further in this Globalization and Health series and
reference the review by Syed et al. [1]. Additional exam-
ples may be found in Govindarajan and Trimble’s work
“Reverse Innovation.”
Specific actions to accelerate the reverse
innovation pipeline
“Skate to where the puck is going to be, not where it
has been.” – Wayne Gretzky
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with Indian leaders at GE
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Price point = $550 USD,




Viewed as a commercial
success by GE leadership
(No publically-available data
on number of units sold)
Success in India
prompted GE to
develop MAC 600 and
MAC 800, adaptations





was sold to primary
care clinics around the
US (no publically-available
data on number of
units sold)
2) Health information Need for gathering
and sharing real-time
information to map the
impact and response to
natural and man-made
disasters
Ushahidi [10], developed in
the aftermath of the 2008
Kenyan presidential election
as a way to map eyewitness
reports of violence
Uses crowdsourcing to
gather critical and timely
information from
smartphones and map
them in a central database
>50 projects in LIC countries
ranging from mapping
Zimbabweans’ opinions on
door-to-door HIV testing to






US and Europe examples
include: used in New
Orleans to report health
hazards and chemical
spillages during hurricanes;
used to promote situational
awareness during the 2012
London Olympics
3) Service delivery Need to provide close-to-
client services and address
underlying social
determinants of health in
resource-limited areas
Partners In Health (PIH) [11]
community health worker
(CHW) and wraparound
service delivery model, first
applied to HIV patients
in rural Haiti
CHWs visit patients at home,
help overcome barriers to
care, and provide psychosocial
support. Food, transport, and
housing support directly
address root causes of disease.
Used by PIH in range of LICs
and adopted by many others.
Likely has passed tipping point,
i.e., 2012 multinational
campaign to train and recruit
one million CHWs in Africa [12].
Adapted to poor urban
US populations by
innovative PIH team,
as the Prevention and




in Boston, PACT reduced
inpatient hospital stays by
35% and decreased hospital
costs by nearly 50% [13]. PACT’s
success influenced similar models
by other US innovators, including





















Figure 3 General electric MACi ECG machine [7].
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RI in health care. It is the proverbial ‘open ice’. Forward-
looking policymakers, entrepreneurs, health system leaders,
and researchers may wish to gain first-mover advantage in
this nascent field. Interestingly, the RI paradigm aligns the
incentives of wealthy actors who need out-of-the-box solu-
tions to intractable problems and poorer settings where
innovation conditions are more favorable. Yet where to
intervene? How do we accelerate the movement of innova-
tions through the RI pipeline?
We offer four recommendations, with specific actions
for policymakers, entrepreneurs, health system leaders,
and researchers:
Recommendation 1 — identify high-priority problems
shared by lower and higher-income countries
 Policymakers and health system leaders could jointly
commission a WHO-led “global to local” initiative to
identify high-priority problems that could be
addressed using RI solutions. Alternatively, this could
be done at the national level through organizations
such as the Institute of Medicine (IOM) in the United
States or the National Institute for Health and Clinical
Excellence (NICE) in the United Kingdom.
 Entrepreneurs could develop a website with three
main functions: (1) facilitating RI problem
identification by patients, providers, and health
system leaders; (2) providing a searchable database
of promising RI solutions; and (3) creating a
marketplace for potential funders and innovators
to convene.
Recommendation 2 — create slack for change,
especially for LIC innovators, LIC early adopters, and
HIC innovators
 Entrepreneurs, foundations, and universities could
jointly organize a global Grand Challenges in
Reverse Innovation competition, to boost visibility
and award seed funding to enable the best RI
solutions to move through the ‘LIC innovation and
spread’ and ‘crossover’ steps of the RI pathway. Researchers could characterize and incentivize the
most promising ideas at the LIC innovator and early
adopter stages through foundation and NIH
funding, creating the necessary benchmarks to
compare such innovations across quality, cost,
and impact.
 Entrepreneurs could invest directly in the best RI
ideas through an online marketplace of ideas,
accelerating their maturation from the innovator to
early adopter stage in LICs, as well as their
crossover to HICs.
 Health system leaders could create RI zones
where outside ideas could be efficiently pilot-
tested (fulfilling Rogers’ ‘easily tested’ and ‘visible
to others’ factors), thereby lowering the barrier
to adoption and facilitating crossover from LICs
to HICs.
Recommendation 3 — create spannable social distances
between LIC early adopters and HIC innovators
 Policymakers, entrepreneurs, and health system
leaders could create new venues for social
interaction between LIC early adopters and HIC
innovators. These could include synchronous
channels, such as conferences, learning
collaboratives, or new roles for innovators to rotate
through lower income settings to observe, compare,
and select appropriate ideas for pilot testing. They
could alternatively include asynchronous channels,
such as email distributions, brief online videos
(e.g., TED-Reverse Innovation), or website blogs.
 Researchers and entrepreneurs could team up as
HIC innovators, leveraging existing infrastructure
for global academic collaboration to discern the
most promising LIC solutions, pilot test them in
HICs, and generate the necessary evidence for
uptake by HIC early adopter populations.
Recommendation 4 — measure reverse innovation
activity globally
 Researchers could use the four-step model for RI in
health care to characterize the state of global RI
activity. We hypothesize that a plurality of
high-potential RI solutions are currently trapped in
Step 2: LIC innovation and spread due to insufficient
resources to advance from the LIC innovator to LIC
early adopter stage, or the absence of spannable
social distances to enable crossover to HIC
innovators.
Conclusions
Many intractable health care problems in wealthy coun-
tries may be more readily solved in developing countries.
This alignment of HIC need and LIC opportunity will
continue to drive proliferation of reverse innovation so-
lutions. Drawing from core concepts in the business and
DePasse and Lee Globalization and Health 2013, 9:40 Page 7 of 7
http://www.globalizationandhealth.com/content/9/1/40innovation literature, we present a model for reverse
innovation in health care with useful implications for ac-
celerating the movement of promising solutions through
the RI pipeline.
We offer four recommendations for forward-looking
policymakers, entrepreneurs, health system leaders, and
researchers who wish to promote reverse innovation in
health care: (1) identify high-priority problems shared by
HICs and LICs; (2) create slack for change, especially for
LIC innovators, LIC early adopters, and HIC innovators;
(3) create spannable social distances between LIC early
adopters and HIC innovators; and (4) measure reverse
innovation activity globally.
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